These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 21107699)

  • 1. Cellular and biomolecular responses of human ovarian cancer cells to cytostatic dinuclear platinum(II) complexes.
    Lin M; Wang X; Zhu J; Fan D; Zhang Y; Zhang J; Guo Z
    Apoptosis; 2011 Mar; 16(3):288-300. PubMed ID: 21107699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisplatin-induced activation of mitogen-activated protein kinases in ovarian carcinoma cells: inhibition of extracellular signal-regulated kinase activity increases sensitivity to cisplatin.
    Persons DL; Yazlovitskaya EM; Cui W; Pelling JC
    Clin Cancer Res; 1999 May; 5(5):1007-14. PubMed ID: 10353733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRCA1-mediated G2/M cell cycle arrest requires ERK1/2 kinase activation.
    Yan Y; Spieker RS; Kim M; Stoeger SM; Cowan KH
    Oncogene; 2005 May; 24(20):3285-96. PubMed ID: 15735702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combined inhibition of PI3K and MEK has synergistic inhibitory effect on the proliferation of cisplatin-resistant ovarian cancer cells].
    Liu Y; Chen X; Luo Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):592-6. PubMed ID: 24909280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tanshinone IIA acts via p38 MAPK to induce apoptosis and the down-regulation of ERCC1 and lung-resistance protein in cisplatin-resistant ovarian cancer cells.
    Jiao JW; Wen F
    Oncol Rep; 2011 Mar; 25(3):781-8. PubMed ID: 21165580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers.
    Serebryanskaya TV; Yung T; Bogdanov AA; Shchebet A; Johnsen SA; Lyakhov AS; Ivashkevich LS; Ibrahimava ZA; Garbuzenco TS; Kolesnikova TS; Melnova NI; Gaponik PN; Ivashkevich OA
    J Inorg Biochem; 2013 Mar; 120():44-53. PubMed ID: 23305964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PIM2 kinase is induced by cisplatin in ovarian cancer cells and limits drug efficacy.
    Musiani D; Hammond DE; Cirillo L; Erriquez J; Olivero M; Clague MJ; Di Renzo MF
    J Proteome Res; 2014 Nov; 13(11):4970-82. PubMed ID: 25099161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genistein induces G2/M cell cycle arrest and apoptosis of human ovarian cancer cells via activation of DNA damage checkpoint pathways.
    Ouyang G; Yao L; Ruan K; Song G; Mao Y; Bao S
    Cell Biol Int; 2009 Dec; 33(12):1237-44. PubMed ID: 19732843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Cytostatic Ruthenium(II)-Platinum(II) Bis(terpyridyl) Anticancer Complex That Blocks Entry into S Phase by Up-regulating p27(KIP1).
    Ramu V; Gill MR; Jarman PJ; Turton D; Thomas JA; Das A; Smythe C
    Chemistry; 2015 Jun; 21(25):9185-97. PubMed ID: 25950156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic insights into antitumor effects of new dinuclear cis Pt(II) complexes containing aromatic linkers.
    Zerzankova L; Kostrhunova H; Vojtiskova M; Novakova O; Suchankova T; Lin M; Guo Z; Kasparkova J; Brabec V
    Biochem Pharmacol; 2010 Aug; 80(3):344-51. PubMed ID: 20399754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tubeimoside I sensitizes cisplatin in cisplatin-resistant human ovarian cancer cells (A2780/DDP) through down-regulation of ERK and up-regulation of p38 signaling pathways.
    Liu HZ; Yu C; Yang Z; He JL; Chen WJ; Yin J; Li WM; Liu HT; Wang YX
    Mol Med Rep; 2011; 4(5):985-92. PubMed ID: 21687949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor properties of salinomycin on cisplatin-resistant human ovarian cancer cells in vitro and in vivo: involvement of p38 MAPK activation.
    Zhang B; Wang X; Cai F; Chen W; Loesch U; Zhong XY
    Oncol Rep; 2013 Apr; 29(4):1371-8. PubMed ID: 23338561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ghrelin enhances cisplatin sensitivity in HO-8910 PM human ovarian cancer cells.
    Leng Y; Zhao C; Yan G; Xu S; Yang Y; Gong T; Li X; Li C
    J Ovarian Res; 2021 Nov; 14(1):162. PubMed ID: 34789301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisplatin resistance in human cervical, ovarian and lung cancer cells.
    Chen J; Solomides C; Parekh H; Simpkins F; Simpkins H
    Cancer Chemother Pharmacol; 2015 Jun; 75(6):1217-27. PubMed ID: 25894720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel monofunctional platinum (II) complex Mono-Pt induces apoptosis-independent autophagic cell death in human ovarian carcinoma cells, distinct from cisplatin.
    Guo WJ; Zhang YM; Zhang L; Huang B; Tao FF; Chen W; Guo ZJ; Xu Q; Sun Y
    Autophagy; 2013 Jul; 9(7):996-1008. PubMed ID: 23580233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of antitumor azolato-bridged dinuclear platinum(ii) complexes with in vivo antitumor efficacy and unique in vitro cytotoxicity profiles.
    Komeda S; Takayama H; Suzuki T; Odani A; Yamori T; Chikuma M
    Metallomics; 2013 May; 5(5):461-8. PubMed ID: 23608770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asiatic acid, a triterpene, induces apoptosis and cell cycle arrest through activation of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways in human breast cancer cells.
    Hsu YL; Kuo PL; Lin LT; Lin CC
    J Pharmacol Exp Ther; 2005 Apr; 313(1):333-44. PubMed ID: 15626723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gambogenic acid induced mitochondrial-dependent apoptosis and referred to phospho-Erk1/2 and phospho-p38 MAPK in human hepatoma HepG2 cells.
    Yan F; Wang M; Li J; Cheng H; Su J; Wang X; Wu H; Xia L; Li X; Chang HC; Li Q
    Environ Toxicol Pharmacol; 2012 Mar; 33(2):181-90. PubMed ID: 22222560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dinuclear Platinum(II) Complexes with Bone-Targeting Groups as Potential Anti-Osteosarcoma Agents.
    Zhang Z; Wang X; Luo C; Zhu C; Wang K; Zhang C; Guo Z
    Chem Asian J; 2017 Jul; 12(13):1659-1667. PubMed ID: 28556606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
    Menendez JA; Vellon L; Colomer R; Lupu R
    Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.